COMPANY
SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD
SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD: API manufacturer for Degarelix, Linaclotide, Liraglutide, Semaglutide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Degarelix | DMF 43215, type II, active, submitted 2025-12-16 Regulator FDA drug master file list |
|---|---|
| Linaclotide | DMF 42635, type II, active, submitted 2025-09-23 Regulator FDA drug master file list |
| Liraglutide | DMF 43515, type II, active, submitted 2026-02-09 Regulator FDA drug master file list |
| Semaglutide | DMF 38213, type II, active, submitted 2023-03-27 Regulator FDA drug master file list |
| Tirzepatide | DMF 44306, type II, active, submitted 2026-06-29 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.